Document Detail


Fluoro-18 fluorodeoxyglucose positron emission tomography/computerized tomography scans in a patient with penile cancer for appropriate therapeutic strategy.
MedLine Citation:
PMID:  17684588     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In patients with penile cancer, positron emission tomography (PET) is important for identifying metastatic lesions and for therapeutic strategy planning. By using PET/computerised tomography -CT scanning, more precise localization and attenuation correction is provided by CT as an additional advantage for diagnosis. A 78-year-old man with squamous cell cancer of the glans penis diagnosed after histopathological examination was referred to our Nuclear Medicine Department PET/CT unit by the Urology Department of our Hospital, for investigation of metastases and for therapeutic strategy planning. There was significantly increased focal fluoro-18 fluorodeoxyglucose (18F-FDG) activity (SUV: 18.2) in the glans penile area and slightly increased activity in the right inguinal region which was described as inflammation by the histopathological examination. There was no other increased abnormal 18F-FDG activity. 18F-FDG PET or PET/CT may be used in squamous cell cancer of the penis for the detection of metastases and for therapeutic strategy planning. Finally, invasive procedures such as total bilateral inguinal lymphadenectomy, having a high morbidity, may be avoided.
Authors:
Metin Halac; Sabri Zincirkeser; Kerim Sönmezoglu; Sait Sager; Haydar Durak; Ilhami Uslu
Related Documents :
17414758 - [f-18]fluorodeoxyglucose positron emission tomography and positron emission tomography:...
19293768 - The evolving role of pet-ct in the management of esophageal cancer.
8153308 - Staging of mediastinal non-small cell lung cancer with fdg pet, ct, and fusion images: ...
1317218 - Screening, diagnosis, and staging of non-small cell lung cancer and consideration of un...
14616218 - Conventional and diffusion-weighted mri in the evaluation of methanol poisoning.
6510558 - Progression of muscular dystrophy assessed by computed tomography.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Hellenic journal of nuclear medicine     Volume:  10     ISSN:  1790-5427     ISO Abbreviation:  Hell J Nucl Med     Publication Date:    2007 May-Aug
Date Detail:
Created Date:  2007-08-08     Completed Date:  2007-11-07     Revised Date:  2010-08-23    
Medline Journal Info:
Nlm Unique ID:  101257471     Medline TA:  Hell J Nucl Med     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  113-5     Citation Subset:  IM    
Affiliation:
Department of Nuclear Medicine, Cerrahpasa Medicine School of Istanbul University Aksaray/Istanbul, Turkey. metinhallac@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Biopsy
Carcinoma, Squamous Cell
Cell Differentiation
Fluorodeoxyglucose F18 / diagnostic use*
Humans
Male
Neoplasms, Squamous Cell / diagnosis*,  radionuclide imaging*,  therapy
Penile Neoplasms / diagnosis*,  radionuclide imaging*,  therapy
Penis / pathology,  radionuclide imaging
Positron-Emission Tomography / methods*
Radiopharmaceuticals / diagnostic use*
Tomography, X-Ray Computed / methods*
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Two cases of synovitis, acne, pustulosis, osteitis--SAPHO syndrome.
Next Document:  Negative gallium-67 citrate and positive positron emission tomography/computed tomography spleen sca...